PapersFlow Research Brief
Hereditary Neurological Disorders
Research Guide
What is Hereditary Neurological Disorders?
Hereditary neurological disorders are inherited conditions affecting the nervous system, characterized by genetic mutations leading to neuropathies such as Charcot-Marie-Tooth disease and hereditary spastic paraplegia, involving mechanisms like axonal degeneration and mitochondrial dysfunction.
Research on hereditary neurological disorders encompasses 26,094 papers focused on genetic mutations, axonal degeneration, nerve growth factor, mitochondrial dysfunction, microtubule dynamics, neurofilament mutations, and ganglioside-induced differentiation. Key studies identify specific genetic causes, such as mutations in the mitochondrial GTPase mitofusin 2 in Charcot-Marie-Tooth neuropathy type 2A (Züchner et al., 2004) and DNA duplications in Charcot-Marie-Tooth disease type 1A (Lupski et al., 1991). Population frequencies of these inherited neuromuscular diseases have been surveyed globally (Emery, 1991).
Topic Hierarchy
Research Sub-Topics
Charcot-Marie-Tooth Disease Genetics
This sub-topic examines genetic mutations in genes such as PMP22, MFN2, and GJB1 associated with different CMT subtypes and their functional consequences on Schwann cells and axons. Researchers study genotype-phenotype correlations, de novo mutations, and modifier genes influencing disease severity.
Hereditary Spastic Paraplegia Pathophysiology
This sub-topic investigates molecular mechanisms of SPG gene mutations leading to corticospinal tract degeneration, including spastin function in microtubule severing and receptor trafficking defects. Researchers explore axonal transport impairments and secondary neurodegeneration in upper motor neurons.
Axonal Degeneration in Hereditary Neuropathies
This sub-topic focuses on Wallerian degeneration pathways, distal axon vulnerability, and regenerative failure in hereditary neuropathies beyond CMT. Researchers analyze die-back mechanisms, organelle transport defects, and neuroprotective interventions in preclinical models.
Mitochondrial Dysfunction in Peripheral Neuropathies
This sub-topic covers mitofusin mutations, impaired mitochondrial fusion/fission, and bioenergetic failure in axonal neuropathies. Researchers study calcium handling defects, ROS production, and mitochondrial axonal transport using patient-derived iPSCs and mouse models.
Neurofilament Mutations in Neuropathies
This sub-topic explores mutations in NEFL, PRPH, and INA genes disrupting neurofilament assembly, axonal caliber, and conduction velocity. Researchers investigate intermediate filament dynamics, aggregation pathology, and biomarkers for disease monitoring.
Why It Matters
Hereditary neurological disorders impact clinical diagnosis and management of conditions like Charcot-Marie-Tooth disease, where mutations in mitofusin 2 cause type 2A neuropathy, as shown by Züchner et al. (2004) with evidence from affected families. DNA duplications on chromosome 17 are associated with Charcot-Marie-Tooth disease type 1A, enabling genetic testing for diagnosis (Lupski et al., 1991). Population surveys provide frequencies, such as those for inherited neuromuscular diseases worldwide, aiding prevalence estimates and resource allocation (Emery, 1991). These findings support targeted therapies addressing axonal degeneration and mitochondrial dysfunction in peripheral neuropathies.
Reading Guide
Where to Start
"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A" by Züchner et al. (2004), as it provides a clear example of a specific genetic cause with clinical relevance for understanding hereditary neuropathy mechanisms.
Key Papers Explained
"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A" (Züchner et al., 2004) identifies a key mutation in axonal neuropathy, building on earlier work like "DNA duplication associated with Charcot-Marie-Tooth disease type 1A" (Lupski et al., 1991), which established genetic duplications in demyelinating forms. "Population frequencies of inherited neuromuscular diseases—A world survey" (Emery, 1991) contextualizes these findings with epidemiological data, while "Assessment of current diagnostic criteria for Guillain-Barré syndrome" (Asbury and Cornblath, 1990) offers diagnostic parallels for peripheral neuropathies.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes genetic mutations in mitofusin 2 and DNA duplications for Charcot-Marie-Tooth subtypes, as detailed in top-cited papers like Züchner et al. (2004) and Lupski et al. (1991). No recent preprints or news in the last 12 months indicate steady progress without major shifts. Frontiers involve integrating population data from Emery (1991) with molecular studies on axonal degeneration.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Frequency Dependence of Signal Power and Spatial Reach of the ... | 2013 | PubMed | 3.7K | ✓ |
| 2 | The Calpain System | 2003 | Physiological Reviews | 2.8K | ✕ |
| 3 | Assessment of current diagnostic criteria for Guillain-Barr� s... | 1990 | Annals of Neurology | 1.9K | ✕ |
| 4 | Biology of Oligodendrocyte and Myelin in the Mammalian Central... | 2001 | Physiological Reviews | 1.7K | ✕ |
| 5 | Guillain-Barré syndrome | 2005 | The Lancet | 1.7K | ✕ |
| 6 | Mutations in the mitochondrial GTPase mitofusin 2 cause Charco... | 2004 | Nature Genetics | 1.5K | ✓ |
| 7 | Guillain-Barré syndrome | 2016 | The Lancet | 1.5K | ✓ |
| 8 | Population frequencies of inherited neuromuscular diseases—A w... | 1991 | Neuromuscular Disorders | 1.4K | ✕ |
| 9 | DNA duplication associated with Charcot-Marie-Tooth disease ty... | 1991 | Cell | 1.3K | ✕ |
| 10 | Veterinary Neuroanatomy and Clinical Neurology | 2009 | Elsevier eBooks | 1.3K | ✕ |
Frequently Asked Questions
What genetic mutation causes Charcot-Marie-Tooth neuropathy type 2A?
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Züchner et al. (2004) identified these mutations in affected families. The mutations disrupt mitochondrial fusion, contributing to axonal degeneration.
What DNA change is linked to Charcot-Marie-Tooth disease type 1A?
DNA duplication associated with Charcot-Marie-Tooth disease type 1A involves a 1.5-Mb duplication on chromosome 17p11.2-p12. Lupski et al. (1991) demonstrated this duplication in patients. It leads to overexpression of peripheral myelin protein-22, causing demyelination.
What are the population frequencies of inherited neuromuscular diseases?
Population frequencies of inherited neuromuscular diseases vary globally, with surveys covering conditions like Charcot-Marie-Tooth and hereditary spastic paraplegia. Emery (1991) conducted a world survey documenting these rates. The data inform genetic counseling and epidemiology.
How do genetic mutations contribute to hereditary neuropathies?
Genetic mutations underlie hereditary neuropathies through mechanisms like axonal degeneration and mitochondrial dysfunction. Züchner et al. (2004) linked mitofusin 2 mutations to Charcot-Marie-Tooth type 2A. Lupski et al. (1991) associated DNA duplications with type 1A.
What role does mitofusin 2 play in neuropathy?
Mitofusin 2 is a mitochondrial GTPase essential for mitochondrial fusion and transport. Mutations in mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A by impairing axonal mitochondrial function (Züchner et al., 2004). This leads to energy deficits and neurodegeneration.
Open Research Questions
- ? How do mitofusin 2 mutations specifically disrupt mitochondrial dynamics in axons to cause Charcot-Marie-Tooth type 2A?
- ? What are the precise mechanisms by which DNA duplications lead to PMP22 overexpression and demyelination in Charcot-Marie-Tooth type 1A?
- ? Can population frequency data for inherited neuromuscular diseases predict regional genetic risks for hereditary spastic paraplegia?
- ? How do neurofilament mutations interact with microtubule dynamics in hereditary neuropathies?
- ? What therapeutic strategies target ganglioside-induced differentiation in axonal degeneration?
Recent Trends
The field of hereditary neurological disorders includes 26,094 works with no specified 5-year growth rate.
Highly cited papers from 2004 (Züchner et al.) and 1991 (Lupski et al., Emery) remain central, focusing on Charcot-Marie-Tooth genetics.
No recent preprints or news coverage in the last 12 months reported.
Research Hereditary Neurological Disorders with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hereditary Neurological Disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers